Nonagen Bioscience Corporation
Irvine, United States (US) · Health and Medical
Do your work at Nonagen Bioscience Corporation?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
#cancer diagnostics
#in vitro diagnostics
#multiplex immunoassays
#urine testing
#bladder cancer diagnostics
#molecular diagnostics
#cancer prognostics
#commercialization
#liquid biopsy
Overview
We are dedicated to providing clinicians with advanced, biomarker-driven tests – like our lead platform, Oncuria® – for the early detection, monitoring, and prediction of bladder cancer recurrence.
Built on a decade of research and supported by $20 million in non-dilutive funding, Oncuria® is a multiplex urine-based liquid biopsy that measures 10 validated protein biomarkers.
By combining rigorous science, clinical validation, and scalable infrastructure, Nonagen Bioscience is bringing precision diagnostics into everyday urologic practice, enabling clinicians to reduce unnecessary procedures and improve patient outcomes.
Contact Details
Irvine, United States (US), 15375 Barranca Pkwy
Founded
2011
Company Type
Private Limited Company
Employees
10-20
Categories
Keywords
#cancer diagnostics
#in vitro diagnostics
#multiplex immunoassays
#urine testing
#bladder cancer diagnostics
#molecular diagnostics
#cancer prognostics
#commercialization
#liquid biopsy
Companies teams usually look at after Nonagen Bioscience Corporation
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.